{"resourceType":"Observation","id":"2a668e18-77dc-5a74-b508-6d6c9696f22a","meta":{"versionId":"1","lastUpdated":"2022-05-24T17:58:36.674-04:00","source":"#GSR59TLAN7lqSlRM","profile":["http://fhir.mimic.mit.edu/StructureDefinition/mimic-observation-micro-test"]},"identifier":[{"system":"http://fhir.mimic.mit.edu/identifier/observation-micro-test","value":"1499971-90134"}],"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"laboratory"}]}],"code":{"coding":[{"system":"http://fhir.mimic.mit.edu/CodeSystem/microbiology-test","code":"90134","display":"EPSTEIN-BARR VIRUS VCA-IgM AB"}]},"subject":{"reference":"Patient/4f773083-7f4d-5378-b839-c24ca1e15434"},"encounter":{"reference":"Encounter/49e3b438-b0b7-5944-9db0-2abae90d6b34"},"effectiveDateTime":"2112-09-17T20:30:00-04:00","valueString":"NEGATIVE <1:10 BY IFA.  INTERPRETATION: RESULTS INDICATIVE OF PAST EBV INFECTION.  In most populations, 90% of adults have been infected at sometime with EBV and will have measurable VCA IgG and EBNA antibodies. Antibodies to EBNA develop 6-8 weeks after primary infection and remain present for life. Presence of VCA IgM antibodies indicates recent primary infection.  ","specimen":{"reference":"Specimen/ce56bcb6-ec58-59cd-a9f2-90eda8cdf933"}}